CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

AngioDefender

Left to right: Dr. Bansal (Heart Institute, Division of Cardiology, Medanta MedCity Hospital) , Alex Charlton (EGI Vice Chairman), Dr. Kasliwal (Chairman of Clinical & Preventive Cardiology, Medanta), Dr. Trehan (Chairman and Founder Medanata), Steve Everist (EGI Director), Dr. Prasad Sunkara (EGI CEO), Tony Kuhn, (EGI Director of Strategic Alliances)

Everist Genomics Bucks Outsourcing Trend, Accelerates Growth Through India

Everist Genomics, a rapidly growing personalized medicine company, announced that it has established a joint-venture company with the Manipal Group, a health care company in India. The joint venture will market EGI’s portfolio of diagnostic, prognostic and therapeutic selection technologies in India.

WWJ Newsradio 950–05/22/2012

Ann Arbor’s Everist Genomics Buys Angiologix Inc.

Everest Genomics announced Monday it has completed the acquisition of 100 percent of the shares of Mountain View, Calif.-based Angiologix Inc., developer of the AngioDefender device for diagnosing heart and vein disease.

WWJ Newsradio 950–10/31/2011